Das „Clinical Oncology and Research Journal” hat einen Artikel von Prof. András Szász zum Thema modulierte Elektro-Hyperthermie veröffentlicht.
Towards the Immunogenic Hyperthermic Action: Modulated ElectroHyperthermia
Abstract
Hyperthermia treatment for solid tumors is a long-used, but poorly accepted method in clinical use. Modulated electro-hyperthermia (mEHT, trade name: oncothermia®) changes the paradigm, introduces a novel, cellularly selective and immunogenic cell-ruination. The mEHT method produces tumor-vaccination, presenting the unharmed genetic information of cancer cells to immune cells [1]. The mEHT method is approved in more than 30 countries. Its phase II/III clinical applications indicate a broad perspective.
